Generic Semaglutide Patent Expiry Unlocks Rs. 50,000 Cr Opportunity for Pharma Industry
The upcoming patent expiry of semaglutide, a leading GLP-1 therapy […]
Read More
The upcoming patent expiry of semaglutide, a leading GLP-1 therapy […]
Read More